Safety and Tolerability of Intravenous Administration of ICVB-1042

Clinical trial NCT05904236 · TERMINATED

Trial details

NCT number: NCT05904236
Sponsor: IconOVir Bio
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Patients With Advanced Solid Tumors

Start date: 2023-06-01
Primary completion: 2024-12-11
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.